Skip to content

Pfizer: Multinational Pharmaceutical

December 21, 2015

Pfizer, Inc. was founded in 1849, in New York City by cousins Charles Pfizer and Charles F. Erhart. It began as a manufacturer of fine chemicals. In  1950 it discovered Terramycin which set it in the direction to becoming a research-based pharmaceutical company.

Organic growth was not the only way the company became a multinational pharmaceutical, it also engaged in acquisitions including very large ones. It acquired Warner-Lambert in 2000, Pharmacia in 2003, and in 2009 it acquired Wyeth for a whopping $68 billion in cash, shares and loan. It cemented Pfizer’s position as the largest pharmaceutical company in the world when the deal was done. It’s not over Pfizer, Inc. is expected to merge with Allergan plc, in 2016, in a deal worth $160 billion to create the Ireland-based “Pfizer plc”.

Headquartered in New York City, the company is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.  Its research headquarters is in Groton, Connecticut.

The research-based global biopharmaceutical company’s global portfolio includes medicines and vaccines, as well as many of the world’s best-know consumer healthcare products. It collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.

Pfizer operates through four operating segments: Primary Care, Speciality Care and Oncology, Established Products & Emerging Markets, and Consumer Healthcare.

The Primary Care segment includes products in therapeutic and disease areas: Alzheimer’s disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory and smoking cessation. The Speciality Care and Oncology segment comprises the Speciality Care business unit and the Oncology business unit.

The Established Products & Emerging Markets segment comprise the Established Products business unit and the Emerging Markets business unit.

The Consumer Healthcare segment includes non-prescriptive products in the following therapeutic categories: dietary supplements, pain management, respiratory and personal care.

In 2014, Pfizer had annual revenue of $49.6 billion and net income of $9.1 billion with around 78,000 employees.

No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: